JPH03112974A - Optically active hemiacetal compound - Google Patents

Optically active hemiacetal compound

Info

Publication number
JPH03112974A
JPH03112974A JP25022689A JP25022689A JPH03112974A JP H03112974 A JPH03112974 A JP H03112974A JP 25022689 A JP25022689 A JP 25022689A JP 25022689 A JP25022689 A JP 25022689A JP H03112974 A JPH03112974 A JP H03112974A
Authority
JP
Japan
Prior art keywords
compound
formula
optically active
lactone
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP25022689A
Other languages
Japanese (ja)
Other versions
JPH0559115B2 (en
Inventor
Seiichi Takano
誠一 高野
Kuniro Ogasawara
国郎 小笠原
Yoichi Shimazaki
洋一 島崎
Kiwa Takehira
竹平 喜和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Soda Co Ltd
Original Assignee
Daiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiso Co Ltd filed Critical Daiso Co Ltd
Priority to JP25022689A priority Critical patent/JPH03112974A/en
Publication of JPH03112974A publication Critical patent/JPH03112974A/en
Publication of JPH0559115B2 publication Critical patent/JPH0559115B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)

Abstract

NEW MATERIAL:An optically active hemiacetal compound of formula I (X' is H or phenylthio; * is asymmetrical carbon). USE:Useful as an intermediate for synthesizing an optically active delta-lactone compound of formula II which is a mother nucleus of delta-lactone antibiotics such as actinobolin and bactobolin. PREPARATION:An optically active delta-lactone compound of formula III is subjected to an 1,4-addition reaction of a cyanoacetic acid ester anion in an inactive solvent such as tetrahydrofuran. The prepared compound of formula IV is reduced with an aluminium hydride reagent such as diisopropyl aluminum halide to provide the compound of formula I. The compound of formula IV is synthesized from glycidyl ether.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明はアクチノボリンやバクトポリン等のδラクトン
系抗生物質の母核をなす式(9)(式中*は不斉炭素を
表わす。) で表わされる光学活性δラクトン化合物を製造する際の
中間体に関する。
[Detailed Description of the Invention] (Industrial Application Field) The present invention is based on formula (9) (in the formula, * represents an asymmetric carbon), which forms the core of δ-lactone antibiotics such as actinovorin and bactoporin. The present invention relates to an intermediate for producing the optically active δ-lactone compound.

(従来の技術及び発明が解決しようとする課題)上記式
(9)で表わされるδラクトン化合物の製造に関しては
、ラセミ体についてはR,Cordova等(Tetr
ahedron Lett、、25.2945(198
4) ) 、に0M。
(Prior art and problems to be solved by the invention) Regarding the production of the δ lactone compound represented by the above formula (9), for the racemate, R, Cordova, etc. (Tetr
ahedron Lett, 25.2945 (198
4) ) , 0M.

PietrUSieWiCZ等(J、Org、Chem
9,53.2837(1988) )が報告しているが
光学活性体についてはに、Hori等(Tetrahe
dron、 匹5295(1985) )が知られてい
るのみである。
PietrUSieWiCZ et al. (J, Org, Chem
9, 53. 2837 (1988)), but regarding optically active substances, Hori et al. (Tetrahe et al.
The only known example is Dron, 5295 (1985).

光学純度の高い該化合物を容易に収率よく得る方法は未
だ知られていない。
A method for easily obtaining this compound with high optical purity in good yield is not yet known.

(課題を解決するための手段) 本発明者は上記の点に鑑み、効率よく、ラセミ化を起す
ことなく簡単な反応経路で、収率よくδラクトン化合物
を得る目的で鋭意検討した結果、下記反応経路(n)に
従い、光学活性δラクトン化合物(6)から光学純度の
高い光学活性δラクトン化合物(9)が容易に得られる
ことを見出した。
(Means for Solving the Problems) In view of the above points, the inventors of the present invention conducted intensive studies to efficiently obtain a δ-lactone compound in a high yield through a simple reaction route without causing racemization, and as a result, they found the following. It has been found that optically active δ-lactone compound (9) with high optical purity can be easily obtained from optically active δ-lactone compound (6) according to reaction route (n).

反応経路(It) (6) (A) (7) 本発明はこの反応経路(n)において得られる中間体を
提供するものである。
Reaction route (It) (6) (A) (7) The present invention provides an intermediate obtained in this reaction route (n).

すなわち、本発明は、 一般式(7) (X’ は水素原子又はフェニルチオ基を、*は不斉炭
素を表わす。) で表わされる光学活性ヘミアセタール化合物(7)を提
供するものである。
That is, the present invention provides an optically active hemiacetal compound (7) represented by the general formula (7) (X' represents a hydrogen atom or a phenylthio group, and * represents an asymmetric carbon).

一般式(7)で表わされる化合物(7)のX′としては
水素原子又はフェニルチオ基が挙げられる。
Examples of X' in compound (7) represented by general formula (7) include a hydrogen atom or a phenylthio group.

本発明の化合物(7)は化合物(6)から化合物(A>
を経て合成され、化合物(6)は、反応経路(I>に従
って、グリシジルエーテル(2)から合成される。
Compound (7) of the present invention can be obtained from compound (6) to compound (A>
Compound (6) is synthesized from glycidyl ether (2) according to reaction route (I>).

すなわち、光学活性なα、β不飽和δラクトン化合物(
6)は、既に本発明者らにより開示された方法(有機合
成化学協会誌45巻、 1157頁(1987) )に
よりグリシジルエーテル(2)から、反応経路(I>に
示すようにして製造することができる。
That is, an optically active α,β-unsaturated δ-lactone compound (
6) can be produced from glycidyl ether (2) by the method already disclosed by the present inventors (Journal of the Society of Organic Synthetic Chemistry, Vol. 45, p. 1157 (1987)) as shown in reaction route (I>). I can do it.

反応経路(1) (2) (3) 〈4) (5)                    (6
)反応経路(I>においてR1は容易に脱離可能な保護
基を表わし、具体的にはベンジル、p−メトキシベンジ
ル、p−クロルベンジル基等のアラルキル基、メトキシ
メチル、t−ブトキシメチル。
Reaction route (1) (2) (3) <4) (5) (6
) In reaction route (I>), R1 represents an easily removable protecting group, specifically an aralkyl group such as benzyl, p-methoxybenzyl, p-chlorobenzyl group, methoxymethyl, t-butoxymethyl.

1−エトキシエチル、 1−イソプロポキシエチル基等
のアルキルオキシアルキル基、アリル、メタリル基等の
アルケニル基又はテトラヒドロフラニル、テトラヒドロ
ピラニル基等の環内に異項原子を含むシクロアルキル基
を表わす。またR2はローブチル、イソブチル、t−ブ
ヂル、メチルなどの低扱アルキル基を表わす。*は不斉
炭素を表わす。
It represents an alkyloxyalkyl group such as 1-ethoxyethyl or 1-isopropoxyethyl group, an alkenyl group such as allyl or methallyl group, or a cycloalkyl group containing a foreign atom in the ring such as tetrahydrofuranyl or tetrahydropyranyl group. Further, R2 represents a lightly treated alkyl group such as lobutyl, isobutyl, t-butyl, and methyl. * represents an asymmetric carbon.

前記反応経路(n)において、Xは水酸基、フェニルチ
オ基若しくは一0R1を、Yは水素原子若しくは−CO
2R3を表わす。X′とR1は上記と同一のものを表わ
し、R3は、メチル、エチル、プロピル、インプロピル
、ブチル、t−ブチル、ペンチル基等炭素数1〜5のア
ルキル基、アリル、2−メチルアリル、2−ブテニル、
3−ブテニル、2−ペンテニル基等炭素数3〜5のアル
ケニル基又はベンジル基を表わす。
In the reaction route (n), X is a hydroxyl group, a phenylthio group, or -R1, and Y is a hydrogen atom or -CO
Represents 2R3. X' and R1 are the same as above, and R3 is an alkyl group having 1 to 5 carbon atoms such as methyl, ethyl, propyl, inpropyl, butyl, t-butyl, pentyl group, allyl, 2-methylallyl, 2 -butenyl,
It represents an alkenyl group having 3 to 5 carbon atoms such as 3-butenyl or 2-pentenyl group, or a benzyl group.

以下詳細反応経路(IIa)、(IIb)に従って、こ
の化合物(6)より出発して化合物(A>より本発明の
化合物(7)を合成する方法を詳細に説明する。
A method for synthesizing compound (7) of the present invention from compound (A>) starting from compound (6) will be described in detail below according to detailed reaction routes (IIa) and (IIb).

詳細反応経路(I[a>、(IIb)において、R1,
R2及びR3はそれぞれ前記と同一のものを表わす。
In the detailed reaction route (I[a>, (IIb)), R1,
R2 and R3 each represent the same thing as above.

またーSphはフェニルチオ基を表わし、*は不斉炭素
を表わす。
-Sph represents a phenylthio group, and * represents an asymmetric carbon.

詳細反応経路(I[a) 詳細反応経路(I[t)) (9) a)δラクトン化合物Aの合成 光学活性α、β不飽和δラクトン化合物(6)に不活性
溶媒、例えばテトラヒドロフラン、エチレングリコール
ジメチルエーテル、トルエン;ジメチルホルムアミドな
どの溶媒中シアノ酢酸エステル(式CH2(CN)CO
2R3中のR3は前記と同一のものを表わす。)のアニ
オンを1,4−付加させて化合物(A−1>(X=OR
1、Y=CO2R’ )を合成し、これから工程1〉エ
ステルの加水分解と脱炭酸、工程2)保護基の脱離。
Detailed reaction route (I[a) Detailed reaction route (I[t)) (9) a) Synthesis of δ-lactone compound A Optically active α,β-unsaturated δ-lactone compound (6) is mixed with an inert solvent, such as tetrahydrofuran, ethylene. Cyanoacetate (formula CH2(CN)CO) in solvents such as glycol dimethyl ether, toluene; dimethylformamide;
R3 in 2R3 represents the same thing as above. ) to form a compound (A-1>(X=OR
1, Y=CO2R') is synthesized, and from this Step 1> Hydrolysis and decarboxylation of the ester, Step 2) Elimination of the protecting group.

工程3)生じた水酸基のフェニルチオ基への変換を行い
、化合物(A−4>(X=SCa Hs 、Y=H)を
合成する。
Step 3) The resulting hydroxyl group is converted to a phenylthio group to synthesize a compound (A-4>(X=SCa Hs , Y=H).

1)エステルの加水分解と脱炭酸、2)保護基の脱離、
3〉生じた水酸基のフェニルチオ基への変換の工程の順
序は1)→2)→3)でも2)→1)→3)でも、2)
→3)→1)でも良い。
1) Hydrolysis and decarboxylation of the ester, 2) Elimination of the protecting group,
3> The order of steps for converting the resulting hydroxyl group into a phenylthio group is either 1) → 2) → 3), 2) → 1) → 3), or 2)
→3) →1) is also fine.

1)、2)、3)の工程は各々それ自体公知の方法によ
って行うことができる。
Steps 1), 2), and 3) can each be performed by methods known per se.

工程1)はアルカリあるいは酸触媒を用い、含水溶媒中
で加熱還流して行う。アルカリとしては炭酸ナトリウム
、炭酸カリウム、水酸化ナトリウム、水酸化カリウムな
どを用いることができる。
Step 1) is carried out using an alkali or acid catalyst and heating under reflux in a water-containing solvent. As the alkali, sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, etc. can be used.

酸としては硫酸、塩酸、臭化水素酸、リン酸などの鉱酸
あるいは塩化マグネシウム、塩化亜鉛、硫酸銅なとのル
イス酸を用いることができる。溶媒としては極性溶媒、
例えばメタノール、エタノール、イソプロピルアルコー
ル、アセトニトリル。
As the acid, mineral acids such as sulfuric acid, hydrochloric acid, hydrobromic acid, and phosphoric acid, or Lewis acids such as magnesium chloride, zinc chloride, and copper sulfate can be used. As a solvent, a polar solvent,
For example, methanol, ethanol, isopropyl alcohol, acetonitrile.

アセトン、ジメチルホルムアミド、ジメチルアセトアミ
ドなどが使用できる。
Acetone, dimethylformamide, dimethylacetamide, etc. can be used.

工程2)の保護基の脱離は選択させるR1により適宜種
々の方法を使いわけることができる。例えばR1がベン
ジル、アリル基のときはパラジウム触媒を用いて水素化
分解あるいは異性化分解の手法が、メトキシメチシャ1
−エトキシエチルの場合は鉱酸や有機酸、ルイス酸を用
いて含水溶媒中で加水分解する手法が使用できる。水酸
基をフェニルチオ基に変換する工程3)はi〜リフェニ
ルホスフィン、トリーローブチルホスフィン、1,2−
ビス(ジフェニルホスフォ)エタンなどの三級ホスフィ
ンの存在下ジフェニルスルフィドと原料のアルコールを
ピリジン、トリエチルアミンなどを溶媒として反応させ
ることにより達成できる。
For removing the protecting group in step 2), various methods can be used as appropriate depending on the R1 selected. For example, when R1 is a benzyl or allyl group, hydrogenolysis or isomerization using a palladium catalyst may be used.
In the case of -ethoxyethyl, a method of hydrolyzing it in a water-containing solvent using a mineral acid, an organic acid, or a Lewis acid can be used. Step 3) of converting a hydroxyl group into a phenylthio group is i~riphenylphosphine, trilobylphosphine, 1,2-
This can be achieved by reacting diphenyl sulfide with a raw material alcohol in the presence of a tertiary phosphine such as bis(diphenylphospho)ethane using pyridine, triethylamine, or the like as a solvent.

また化合物(A−1)(X=OR1、Y−CO2R3)
を工程2)→3)→1)の経路で反応させると化合物(
A−5)(X−OH,Y=CO2R3)、(A−6>(
X=SC6t−1s 、Y=CO2R3)を経て化合物
(A−4>(X=SC8R5、Y=H)に導くこともで
きる。
Also, compound (A-1) (X=OR1, Y-CO2R3)
When reacting through the route of steps 2) → 3) → 1), the compound (
A-5) (X-OH, Y=CO2R3), (A-6>(
It is also possible to lead to the compound (A-4>(X=SC8R5, Y=H) via X=SC6t-1s, Y=CO2R3).

化合物(A−1>(X=OR’ 、Y=CO2R3)か
ら化合物(△−4>(X=SCs Hs 。
Compound (A-1>(X=OR', Y=CO2R3) to compound (Δ-4>(X=SCs Hs).

Y−H)への変換の異体例を以下に示すが、製法はこの
具体例に限られるものではない。
Examples of variants for conversion to YH) are shown below, but the production method is not limited to these specific examples.

化合物(A−1>(X=OBn、Bnはベンジル基を示
す。Y=CO2C21−1s )を塩化マグネシウムと
ジメチルアセトアミド中で加熱し、加水分解・脱炭酸し
、シリカゲルカラムクロマトグラフィーで分離、精製し
、化合物(A−2>(X=OBn、Y=H)のトランス
体、シス体を各々得ることができる。このものをパラジ
ウム触媒を用い、水素化分解し、化合物(A−3)(X
=OH。
Compound (A-1>(X=OBn, Bn represents a benzyl group. Y=CO2C21-1s) was heated in magnesium chloride and dimethylacetamide, hydrolyzed and decarboxylated, and separated and purified by silica gel column chromatography. Then, the trans and cis forms of compound (A-2>(X=OBn, Y=H) can be obtained respectively. This is hydrogenolyzed using a palladium catalyst to obtain compound (A-3) ( X
=OH.

Y=H)とし、トリーn−ブヂルホスフィン、ジフェニ
ルスルフィドとピリジン中で反応させて化合物(A−4
)(X=SCe Hs 、Y−ト1)を得る。
Y=H) and reacted with tri-n-butylphosphine and diphenyl sulfide in pyridine to form the compound (A-4
) (X=SCe Hs , Y-t1) is obtained.

b)へミアセタール化合物(7)の合成化合物(A−4
)(X=SCe Hs 、Y=H)をジイソブチルアル
ミニウムハイドライドなどの水素化アルミニウム試剤で
還元するとヘミアセタール(7−1>が得られる。反応
はテトラヒドロフラン、■チレングリコールジメチルエ
ーテル。
b) Synthetic compound of hemiacetal compound (7) (A-4
) (X=SCe Hs , Y=H) is reduced with an aluminum hydride reagent such as diisobutylaluminum hydride to obtain hemiacetal (7-1>.The reaction is performed with tetrahydrofuran, ① tyrene glycol dimethyl ether.

ジオキサンなどの不活性溶媒中、O〜−80’の低温で
行う。化合物(7−2)(X’ =H)は化合物(7−
1)  (X’ =−3Cs Hs )をラネーニッケ
ルを用いて還元することにより得られる。
It is carried out in an inert solvent such as dioxane at a low temperature of O to -80'. Compound (7-2) (X' = H) is compound (7-
1) Obtained by reducing (X' = -3Cs Hs) using Raney nickel.

本発明の化合物(7)は前記反応経路(n)に従って、
光学活性δラクトン化合物(9)とすることができる。
Compound (7) of the present invention can be prepared according to the reaction route (n),
It can be an optically active δ-lactone compound (9).

以下順に説明する。They will be explained in order below.

C)カルボン酸エステル化合物Bの合成化合物(7−1
)を一般式R30COCH−PZR4(8)で表わされ
るp−イリド(式(8)で7は酸素、(OR3)2また
は(Cs R5) 2を、R4はOR3またはC6Hs
を、R3は前記と同一のものを表わす。)と反応させて
化合物(B−1>(D−E:CH=CH,X’ =SC
eHs)を得る。化合物(B−1)から化合物(C−2
>(X’ =H>へは工程4)二重結合の還元。
C) Synthetic compound of carboxylic acid ester compound B (7-1
) is a p-ylide represented by the general formula R30COCH-PZR4 (8) (in formula (8), 7 is oxygen, (OR3)2 or (Cs R5)2, and R4 is OR3 or C6Hs
, R3 represents the same thing as above. ) to form a compound (B-1>(D-E:CH=CH,X'=SC
eHs). From compound (B-1) to compound (C-2
>(X'=H> Step 4) Reduction of double bond.

工程5)フェニルチオ基の還元、工程6)ニトリルの加
水分解、工程7)δラクトン環への閉環の4つの工程を
行うことにより達成できる。尚、化合物(7−2)(X
’ =H)を原料とした場合は工程5)は必要ない。
This can be achieved by performing four steps: step 5) reduction of the phenylthio group, step 6) hydrolysis of the nitrile, and step 7) ring closure to a δ-lactone ring. In addition, compound (7-2) (X
'=H) is used as a raw material, step 5) is not necessary.

この4つの工程は工程7)のまえに工程6〉を行う事を
除き、各々独立しており、どの順序で行ってもよい。ま
た4)、5)の工程、6)、7)の工程を同時に行うこ
ともできる。各々の工程はそれ自体公知の方法により行
うことができる。すなわち、工程4)二重結合の還元は
亜鉛−酢酸あるいはパラジウム、白金、ラネーニッケル
等による接触水素化により行うことができ、工程5)の
フェニルチオ基の還元はラネーニッケルによる接触還元
で達成できる。工程6)のニトリルの加水分解は塩酸、
硫酸、臭化水素酸なとの鉱酸を用いるか水酸化ナトリウ
ム、水酸化カリウムなどの塩基を用いて含水溶媒中で加
熱すれば達成できる。
These four steps are independent, except that step 6> is performed before step 7), and may be performed in any order. Further, steps 4) and 5), and steps 6) and 7) can be performed simultaneously. Each step can be performed by a method known per se. That is, step 4) reduction of double bonds can be achieved by catalytic hydrogenation with zinc-acetic acid, palladium, platinum, Raney nickel, etc., and step 5) reduction of phenylthio groups can be achieved by catalytic reduction with Raney nickel. Hydrolysis of nitrile in step 6) is carried out using hydrochloric acid,
This can be achieved by heating in a water-containing solvent using a mineral acid such as sulfuric acid or hydrobromic acid or a base such as sodium hydroxide or potassium hydroxide.

また工程7)のδラクトン環への閉環はニトリルの加水
分解で生じたカルボン酸を酸処理すれば達成できる。こ
れらの各工程を適宜選択すれば望ましい生成物を選択的
に得ることができる。
Further, the ring closure to the δ-lactone ring in step 7) can be achieved by acid-treating the carboxylic acid produced by hydrolysis of the nitrile. By appropriately selecting each of these steps, desired products can be selectively obtained.

例えば化合物(B−1>(D−E:CH=CH。For example, the compound (B-1>(D-E:CH=CH.

X’ −3Cs Hs )を亜鉛−酢酸で還元すると化
合物(B−2)  (D−E :CH2CH2、X’ 
=SCe Hs )が得られ、化合物(B−1>(DE
 :CH=CH,X’ =SCs Hs )をラネーニ
ッケルで還元するとフェニルチオ基の還元と二重結合の
還元が同時におこり、化合物(B−3>(D−E : 
CH2CH2、X’ =l−1)が得られる。
When X'-3Cs Hs) is reduced with zinc-acetic acid, compound (B-2) (D-E: CH2CH2, X'
=SCe Hs ) was obtained, and the compound (B-1>(DE
:CH=CH,
CH2CH2, X' = l-1) is obtained.

d)δラクトン化合物Cの合成 上記化合物(B−3)のニトリル基を水酸化ナトリウム
存在下、エタノール中加熱還流して加水分解し、生じた
カルボン酸を塩酸で処理してδラクトン化合物(C−2
)(X’ =H,R3=H>とし、低扱アルコールと酸
触媒存在下で反応させるか、ジアゾメタンと反応させエ
ステル化して化合物(C−2)(X’ =H)とする。
d) Synthesis of δ-lactone compound C The nitrile group of the above compound (B-3) is hydrolyzed by heating under reflux in ethanol in the presence of sodium hydroxide, and the resulting carboxylic acid is treated with hydrochloric acid to produce δ-lactone compound (C). -2
) (X' = H, R3 = H>, and the compound (C-2) (X' = H) is obtained by reacting with a low-handling alcohol in the presence of an acid catalyst or by reacting with diazomethane for esterification.

工程5)のフェニルチオ基の還元は化合物(B)から(
C)への変換の際行う代りに化合物(C)から(9)へ
の変換の際に行っても良い。この場合は化合物(B)か
ら(C)への工程4)を亜鉛−酢酸もしくはパラジウム
や白金による水素化で行い、工程6)、7)を前)ホの
方法で行って化合物(C−1>(X’ −3Ce Hs
 )を得、これをラネーニッケルで水素化し、化合物(
C−2>(X’ =ト1)としたのち最後の分子内縮環
反応を行う。
In step 5), the phenylthio group is reduced from compound (B) to (
Instead of carrying out during the conversion to C), it may be carried out during the conversion from compound (C) to (9). In this case, step 4) from compound (B) to (C) is carried out by hydrogenation with zinc-acetic acid or palladium or platinum, and steps 6) and 7) are carried out by the method of previous step (e) to form compound (C-1). >(X'-3Ce Hs
) was hydrogenated with Raney nickel to give the compound (
After setting C-2>(X'=t1), the final intramolecular ring condensation reaction is performed.

ここで得られたδラクトン化合物(A)、ヘミアセター
ル化合物く7)、カルボン酸エステル化合物(B)及び
δラクトン化合物(C)はいずれも文献未記載の新規化
合物であり、次に述べる光学純度の高いδラクトン化合
物(9)を製造する上で重要な中間体でおる。
The δ lactone compound (A), hemiacetal compound 7), carboxylic acid ester compound (B), and δ lactone compound (C) obtained here are all new compounds that have not been described in literature, and have the optical purity described below. It is an important intermediate in producing the high δ-lactone compound (9).

e)δラクトン化合物(9)の合成 化合物(C−2)(X’ =H)の分子内縮環反応は不
活性溶媒、例えばテトラヒドロフランやエチレングリコ
ールジメヂルエーテル、 t−ブタノール、ジメチルホ
ルムアミド ム−t−ブトキシド、水素化ナトリウム、水酸化ナトリ
ウム、水酸化カリウムなどの塩基と反応させて公知の目
的物質,光学活性δラクトン化合物(9)を光学純度よ
く高収率で得る事ができる。
e) Synthesis of δ-lactone compound (9) The intramolecular ring condensation reaction of compound (C-2) (X' = H) is carried out using an inert solvent, such as tetrahydrofuran, ethylene glycol dimedyl ether, t-butanol, dimethylformamide. By reacting with a base such as t-butoxide, sodium hydride, sodium hydroxide, potassium hydroxide, etc., the known target substance, optically active δ-lactone compound (9), can be obtained with good optical purity and high yield.

(発明の効果) 本発明の光学活性化合物はδラクトン系抗生物質の母核
をなす化合物を製造する際の中間体として重要な化合物
でおって、この化合物を用いることにより光学純度の高
いδラクトン化合物(9)を効率よく製造することがで
きる。
(Effects of the Invention) The optically active compound of the present invention is an important compound as an intermediate in the production of compounds that form the core of δ-lactone antibiotics, and by using this compound, δ-lactone with high optical purity can be produced. Compound (9) can be efficiently produced.

(実施例) 以下具体例を実施例にもとづき、述べる。(Example) Specific examples will be described below based on Examples.

実施例1 1)化合物(A−1>の合成 <6)                   (A〜
1)(Bnはベンジル基,Etはエチル基を表わす。
Example 1 1) Synthesis of compound (A-1><6) (A~
1) (Bn represents a benzyl group, Et represents an ethyl group.

以下同じ。) アルゴン気流下、シアン酢酸エチルエステル1、24g
(l1m)!>を鉱油でけんだくした60W/W%の水
素化ナトリウム440mCI ( 11mM>のテトラ
ヒドロフラン15mlけんだく液中に水冷下で加え10
分間室温で撹拌した。次に8体のα,β不飽和δラクト
ン(6 ) 2.09 ( 9. 17mM>のテトラ
ヒドロフラン溶液57!を氷冷下ゆっくり加え、同温で
1時間撹拌した。反応液をジエチルエーテル5(7で希
釈し、10%塩酸を加え中和し、分液し、有機層を飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後、減圧
上溶媒を留去すると1.4−付加体(A−1>が黄色油
状物質として3,5g得られた。
same as below. ) Under argon flow, cyanacetic acid ethyl ester 1.24g
(l1m)! > was added under water cooling to 440 mCI (11 mM) of 60 W/W% sodium hydride suspended in mineral oil in 15 ml of tetrahydrofuran.
Stir for minutes at room temperature. Next, 57! of a tetrahydrofuran solution containing 2.09 (9.17mM) of 8 α,β-unsaturated δ-lactones (6) was slowly added under ice cooling and stirred at the same temperature for 1 hour.The reaction solution was diluted with diethyl ether 5 ( The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the 1.4-adduct (A -1> was obtained as a yellow oily substance in an amount of 3.5 g.

’HNMR (CDCb ) δ:1.32 ( 3H, t, J=7.1Hz >
2.0  (2H,m) 2.60 (2H,m> 2.90 (11−1,m) 3.60 (、]七m) 4.30(2H,Q、 J=7.111z >4.56
(2H,S) 4.60(IH,m) 7゜33(5H,5) IR(口eat) 2940、2250.1740. 740. 700M
5  m/e 332 (M+ 1 > 、 91 (100%)2)
化合物(A−2)の合成 m−1 (A−1>              (A−2)ア
ルゴン気流下、上記1,4−付加体(A−1>3.5g
を水10滴、塩化マグネジ「タム6水塩1 、86g(
9,17mM)とジメチルアセトアミド30rd!中で
170’C,12時間加熱還流し、室温にもどしたのら
、水とジエチルエーテルを加え、抽出分離し、水層は塩
酸で酸性にしたのら酢酸エチルで抽出した。有機層をあ
わUて無水硫酸マグネシウムで乾燥し、減圧上溶媒を留
去し、残渣をベンゼン50m1にとかし、12時間加熱
還流した。次に反応液を減圧上溶媒を留去し、残漬をシ
リカゲルカラムクロマトグラフィーに付し、エーテル:
ヘキサン(100:1v/v )流出し、3R,53の
δラクトン化合物(八−2)を無色油状物質として1.
47(7((6)より62%)得た。更にエーテルで溶
出して33.53のδラクトン化合物(A−2)  1
85mq ((6) ヨV)7.8%)を得た。3R,
5Sのδラクトン化合物(八−2)のデータは次の通り
でおる。
'HNMR (CDCb) δ: 1.32 (3H, t, J=7.1Hz >
2.0 (2H, m) 2.60 (2H, m> 2.90 (11-1, m) 3.60 (, ]7 m) 4.30 (2H, Q, J=7.111z >4 .56
(2H, S) 4.60 (IH, m) 7°33 (5H, 5) IR (mouth eat) 2940, 2250.1740. 740. 700M
5 m/e 332 (M+ 1 > , 91 (100%) 2)
Synthesis of compound (A-2) m-1 (A-1> (A-2) Under an argon atmosphere, the above 1,4-adduct (A-1>3.5 g
10 drops of water, 1 part of chloride magnezi "Tam 6 water salt, 86 g (
9,17mM) and dimethylacetamide 30rd! The mixture was heated under reflux at 170'C for 12 hours, returned to room temperature, extracted and separated by adding water and diethyl ether, and the aqueous layer was acidified with hydrochloric acid and extracted with ethyl acetate. The organic layer was briefly dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was dissolved in 50 ml of benzene and heated under reflux for 12 hours. Next, the solvent was distilled off from the reaction solution under reduced pressure, and the residue was subjected to silica gel column chromatography.
1. Hexane (100:1v/v) flows out and the δ-lactone compound (8-2) of 3R, 53 is converted into a colorless oil.
47 (7 (62% from (6)) was obtained. Further elution with ether yielded 33.53 δ lactone compound (A-2) 1
85 mq ((6) YoV) 7.8%) was obtained. 3R,
The data for the 5S δ-lactone compound (8-2) are as follows.

’HNMR(CDCb ) δ:1.7〜2.9  (7H,m) 3.65        (2H,d、  J=4.4
tlz  >4.58    (2H,S) 4.6    (IH,m> 7.33    (5H,5) IR(neat) 2940、2250.7740. 742. 7(10
MS  m/e 259 (M+ ) 、 91 (100%)3)化合
物(A−3>の合成 m−1 (A−2>              (A−3>上
記3R,53体のδラクトン化合物(A−2>1.38
(1(5,33mt(>を酢fljエチル40m1にと
がし、水酸化パラジウム180mg、濃塩酸1滴を加え
水素ガス雰囲気下至温で3時間撹拌した。反応液をセラ
イトろ過し、減圧上溶媒を留去し、残漬をシリカゲルカ
ラムクロマトグラフィーに付し、酢酸エチル留分より化
合物(A−3>を無色油状物質として866、7rUJ
、9た。収率96%IHNMR(CDα3) δ:1.65〜3.1 (81−1,m>3.78  
  (2H,m> 4゜57     (1H,5extet、  J=4
.4HzIR(neat) 333()、 2250.1735  cm−1MS 
 m/e 170(M+’l)、  138(100%)4)化合
物(A−4)の合成 ) (A−3)                 (A−
4>(phはフェニル基を、Buはブチル基を表わす。
'HNMR (CDCb) δ: 1.7-2.9 (7H, m) 3.65 (2H, d, J=4.4
tlz >4.58 (2H,S) 4.6 (IH,m>7.33 (5H,5) IR(neat) 2940, 2250.7740. 742.7 (10
MS m/e 259 (M+), 91 (100%) 3) Synthesis of compound (A-3> m-1 (A-2>(A-3> 3R, 53 δ-lactone compound (A-2) >1.38
(1 (5,33 mt) was dissolved in 40 ml of ethyl acetate, 180 mg of palladium hydroxide and 1 drop of concentrated hydrochloric acid were added, and the mixture was stirred at the lowest temperature in a hydrogen gas atmosphere for 3 hours. The reaction solution was filtered through Celite, and then poured under reduced pressure. The solvent was distilled off, the residue was subjected to silica gel column chromatography, and the compound (A-3> was converted into a colorless oily substance from the ethyl acetate fraction, 866,7rUJ).
,9. Yield 96% IHNMR (CDα3) δ: 1.65-3.1 (81-1, m>3.78
(2H, m> 4゜57 (1H,5extet, J=4
.. 4HzIR(neat) 333(), 2250.1735 cm-1MS
m/e 170 (M+'l), 138 (100%) 4) Synthesis of compound (A-4)) (A-3) (A-
4>(ph represents a phenyl group, Bu represents a butyl group.

以下同じ。) アルゴン気流下、上記化合物(△−3) somg(0
,296mM> 、ジフェニルジスルフィド193mg
< 0.888m)l) 、  トリー〇−ブヂルフォ
スフィン0.22d (0,888mM)をピリジン2
mlに加え、室温で12時間撹拌する。反応液を酢酸エ
チル30mf!で希釈し、10%塩酸で洗浄し、次いで
飽和硫酸銅水溶液、飽和型費水、飽和食塩水の順に洗浄
し、無水5A酸マグネシウムで乾燥し、減圧上溶媒留去
し、残渣をシリカゲルカラムクロマトグラフィーにイ寸
し、エーテル留分より、フェニルスルフィド(A−4>
 71mg (92%)を得た。
same as below. ) Under an argon stream, the above compound (Δ-3) somg(0
, 296mM>, diphenyl disulfide 193mg
0.22d (0.888mM) of tri-butylphosphine was added to pyridine 2
ml and stirred at room temperature for 12 hours. Pour the reaction solution into 30mf of ethyl acetate! The solution was diluted with water, washed with 10% hydrochloric acid, then washed with saturated copper sulfate aqueous solution, saturated water, and saturated saline in that order, dried over anhydrous magnesium 5A acid, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography. Phenyl sulfide (A-4>
71 mg (92%) was obtained.

’HNMR(CDC13) δ: 1.85〜2.75 (7H,m>2.94  
  (IH,dcf、 J=14.5.9.011z 
)3.30    (IH,dd、 J=14.5.5
.8tlZ )4.45    (IH,tt、 J=
 9.0.5.8tlz )7.30        
(5H,m>IR(neat) 2930、2250.1740. 740. 695 
 cm−1MS  m/e 261 (M” ) 、  123 (100%)5)
化合物(7−1)の合成 (A−4)                (7−1
>アルゴン気流下、上記フェニルスルフィド(A−4)
  984mg(3,77mM)のテトラヒドロフラン
溶液25m1に一30℃撹拌下ジインブチルアルミニウ
ムハイドライドの2Mトルエン溶液2m1(4mM>を
ゆっくり加え、−30’Cで10分間撹拌した。反応液
に10%NaOH水溶液を少但加え、室温で2時間撹拌
し、セライトろ過した後、減圧上溶媒を貿去し、ヘミア
セタール(7−’l)  986+ngを得た。
'HNMR (CDC13) δ: 1.85-2.75 (7H, m>2.94
(IH, dcf, J=14.5.9.011z
)3.30 (IH, dd, J=14.5.5
.. 8tlZ ) 4.45 (IH, tt, J=
9.0.5.8tlz)7.30
(5H, m>IR(neat) 2930, 2250.1740. 740. 695
cm-1MS m/e 261 (M”), 123 (100%)5)
Synthesis of compound (7-1) (A-4) (7-1
> Under argon flow, the above phenyl sulfide (A-4)
To 25 ml of a solution of 984 mg (3,77 mM) in tetrahydrofuran was slowly added 2 ml (4 mM) of a 2M toluene solution of diimbutylaluminum hydride under stirring at -30°C, and the mixture was stirred at -30'C for 10 minutes. A 10% NaOH aqueous solution was added to the reaction solution. A small amount of the mixture was added, stirred at room temperature for 2 hours, filtered through Celite, and the solvent was removed under reduced pressure to obtain 986+ ng of hemiacetal (7-'l).

’HNMR(CDC13) δ :1.5 〜1.9   (4,H,m>2.2〜
2.5  (2H,m> 2.7     (11−(、m) 2.9〜3.6  (2H,m) 3.7〜4.4  (IH,m> 5.0 〜5.4   (IH,m> 7.2〜7.45 (51−1,m) IR(neat) 3400、2910.2250. 745. 695 
 cm−IMS  m/e 263 (M+ ) 、  124 (100%)合成
例 化合物(B−1>の合成 <7−1 )                  (
B−1)アルゴン気流下、上記へミアセタール(7−1
>986m(1(3,75m)りの塩化メチレン溶液2
07!にトリフェニルフォスフインのエトキシカルボニ
ルメチルイリド3,9q (11,25mM>を加え、
室温で15時間撹拌する。反応液を減圧上溶媒留去し、
残渣をシリカゲルカラムクロマトグラフィーに付し、エ
ーテル:ヘキサン(3:I V/V)留分より5−シア
ンメチル−7−ヒドロキシ−8−フェニルチオオクタ−
2−エノイツクアシツドエチルエステル(8−1)を1
.03(] (882%無色油状物質として得た。
'HNMR (CDC13) δ: 1.5 ~ 1.9 (4, H, m > 2.2 ~
2.5 (2H, m> 2.7 (11-(, m) 2.9 to 3.6 (2H, m) 3.7 to 4.4 (IH, m> 5.0 to 5.4 ( IH, m> 7.2 ~ 7.45 (51-1, m) IR (neat) 3400, 2910.2250. 745. 695
cm-IMS m/e 263 (M+), 124 (100%) Synthesis of synthesis example compound (B-1><7-1) (
B-1) Under an argon stream, the above hemiacetal (7-1
>986 m (1 (3,75 m) methylene chloride solution 2
07! Add 3,9q (11,25mM) of triphenylphosphine ethoxycarbonylmethyl ylide to
Stir at room temperature for 15 hours. The solvent was distilled off from the reaction solution under reduced pressure,
The residue was subjected to silica gel column chromatography, and from the ether:hexane (3:IV/V) fraction, 5-cyanmethyl-7-hydroxy-8-phenylthiooct-
2-enoic acid ethyl ester (8-1)
.. 03(] (882% obtained as a colorless oil.

’HNMR(CDCb ) δ :1.29        (3H,t、  J=
7.1Hz  >1.80        (2H,m
)2.0〜2.7  (51−1,m) 2.68    (IH,dd、 J=13.9.8.
atlZ )3.15    (IH,dd、 J=1
3.9.3.7Hz >3.70      (IH,
m> 4.90       (2H,(1,J=  7.1
Hz>5.90    (IH,d、 J=15.6H
z)6.80    (IH,dt、 J=15.6.
7.1H2)IR(neat) 3450、2910.2250.1910.1650゜
740、 690  cm−1 MS  m/e 333 (M+ ) 、  124 (100%)化合
物(B−3>の合成 (B−1>                 (B−
3)(Meはメチル基を表わす。以下同じ。)上記化合
物(B−1> 87mg(0,26mM)のエタノール
1ml溶液にラネーニッケル0.6mMのエタノ−ル溶
液0.6mlを加え、90℃で20分加熱還流した後、
反応液をセライトろ過し、減圧上溶媒を留去し、残漬を
シリカゲルカラムクロマトグラフィーにイ寸し、エーテ
ル:ヘキサン(7:I V/V)留分より化合物(3−
3) 37.2mg (63%)を無色油状物質として
得た。
'HNMR (CDCb) δ: 1.29 (3H, t, J=
7.1Hz >1.80 (2H, m
)2.0~2.7 (51-1, m) 2.68 (IH, dd, J=13.9.8.
atlZ ) 3.15 (IH, dd, J=1
3.9.3.7Hz >3.70 (IH,
m> 4.90 (2H, (1, J= 7.1
Hz>5.90 (IH, d, J=15.6H
z) 6.80 (IH, dt, J=15.6.
7.1H2) IR (neat) 3450, 2910.2250.1910.1650°740, 690 cm-1 MS m/e 333 (M+), 124 (100%) Synthesis of compound (B-3> (B-1 > (B-
3) (Me represents a methyl group. The same applies hereinafter.) Add 0.6 ml of an ethanol solution of 0.6 mM Raney nickel to a 1 ml ethanol solution of the above compound (B-1> 87 mg (0.26 mM), and heat at 90°C. After heating under reflux for 20 minutes,
The reaction solution was filtered through Celite, the solvent was distilled off under reduced pressure, the residue was subjected to silica gel column chromatography, and the compound (3-
3) Obtained 37.2 mg (63%) as a colorless oil.

’HNMR(CDC1:+ ) δ:1.23    (3H,d、 J=6.3tlz
 >1.26    (31−1,t、 J=7.1[
IZ )t4〜1.8  (7H,m> 1.95    (IH,m> 2.33    (2H,t、 J=6.6Hz >2
.48    (2H,d、 J=5.4Hz )3.
90    (IH,m> 4.14    (2f−1,q、 J=7.1tlz
 )IR(neat) 3400、2250.1725  cm−1MS  m
/e 228 (M+1 > 、  164 (ioo%)化
合物(C−2>の合成 (B−3>                  (C
−21アルゴン気流下、上記化合物(B−3>  25
0mg(1,1m)f)を30%水酸化カリウム水溶液
1m、エタノール8dにとかし、12時間加熱還流した
。反応液にエーテル30m1.水20mを加え、抽出分
離し、水層に濃塩酸を加え酸性とし、塩化メチレンで抽
出した。有機層をあわせて無水硫酸マグネシウムで乾燥
し、減圧上溶媒を留去した。残渣を塩化メチレンでとか
し、ジアゾメタンのエーテル溶液を加えてメチルエステ
ルとした。これを減圧上溶媒留去し、残漬をシリカゲル
カラムクロマトグラフィーに付し、エーテル:ヘキサン
(1:I V/V)留分J=す(C−2>  192.
1mg(82%)を無色結晶として得た。
'HNMR (CDC1:+) δ:1.23 (3H, d, J=6.3tlz
>1.26 (31-1,t, J=7.1[
IZ)t4~1.8 (7H,m>1.95 (IH,m>2.33 (2H,t, J=6.6Hz>2
.. 48 (2H, d, J=5.4Hz)3.
90 (IH, m> 4.14 (2f-1, q, J=7.1tlz
)IR(neat) 3400, 2250.1725 cm-1MS m
/e 228 (M+1>, 164 (ioo%) Synthesis of compound (C-2>) (B-3> (C
-21 Under an argon stream, the above compound (B-3>25
0mg (1,1m)f) was dissolved in 1m of 30% aqueous potassium hydroxide solution and 8d of ethanol, and heated under reflux for 12 hours. Add 30 ml of ether to the reaction solution. 20 ml of water was added, extracted and separated, and the aqueous layer was made acidic by adding concentrated hydrochloric acid, and extracted with methylene chloride. The organic layers were combined and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was dissolved with methylene chloride, and an ether solution of diazomethane was added to give a methyl ester. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography to obtain an ether:hexane (1:IV/V) fraction J=S(C-2>192.
1 mg (82%) was obtained as colorless crystals.

mp    72.5〜73℃ 1−(NMR(CQCJ13) (3H,d、 J=6.3Hz ) (11H,m) (3H,S) (1H,m> 2900、1720  cm−1 δ:1.38 1.1〜2.9 3.68 4.4 IR(CHα3) MS  m/e 215(M+1 化合物(9)の合成 )、74( 100%) (C−2)                   (
9)アルゴン気流下、化合物(C−2>  178mg
(0,83m)l )のテトラヒドロフラン溶液2ml
をカリウム−t−ブトキシド289.5mg (2,6
8n+H)のテトラヒドロフランけんだく液8mlに至
温で加え、更に同温度で10分間撹拌した。反応液に水
20d、エーテル30mff1を加え、抽出分離した。
mp 72.5-73°C 1-(NMR (CQCJ13) (3H, d, J=6.3Hz) (11H, m) (3H, S) (1H, m> 2900, 1720 cm-1 δ: 1. 38 1.1-2.9 3.68 4.4 IR (CHα3) MS m/e 215 (M+1 Synthesis of compound (9)), 74 (100%) (C-2) (
9) Under argon flow, compound (C-2> 178 mg
2 ml of tetrahydrofuran solution of (0.83 ml)
Potassium-t-butoxide 289.5 mg (2,6
The mixture was added to 8 ml of a suspension of 8n+H) in tetrahydrofuran at very room temperature, and further stirred at the same temperature for 10 minutes. 20 d of water and 30 mff of ether were added to the reaction solution, and the mixture was extracted and separated.

水層を濃塩酸で酸性とし、塩化メチレンで抽出し、有R
層をあわせて無水硫酸マグネシウムで乾燥した後、減圧
下で溶媒を留去し、残渣をシリカゲルカラムクロマトグ
ラフィーに付し、エーテル:ヘキサン(1:5 v/v
)m分より化合物(9)  1061106l11%)
を無色針状晶として得た。
The aqueous layer was made acidic with concentrated hydrochloric acid, extracted with methylene chloride, and
After the layers were combined and dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography.
) Compound (9) 1061106l11%)
was obtained as colorless needles.

m0121〜122°C (lit、 mp 120〜121°C,F、tl、5
todola、et al。
m0121~122°C (lit, mp 120~121°C, F, tl, 5
todola, et al.

Biochem、J、、93.92(1964))[α
]ダ+18.1° (cm1゜03.エタノール)(l
it、 [α] D+18.2° (cm1.15.エ
タノール。
Biochem, J., 93.92 (1964)) [α
] da+18.1° (cm1°03.ethanol) (l
it, [α] D+18.2° (cm1.15. Ethanol.

Claims (1)

【特許請求の範囲】 一般式(7) ▲数式、化学式、表等があります▼(7) (X′は水素原子又はフェニルチオ基を、*は不斉炭素
を表わす。) で表わされる光学活性ヘミアセタール化合物。
[Claims] General formula (7) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(7) (X' represents a hydrogen atom or a phenylthio group, and * represents an asymmetric carbon.) Acetal compound.
JP25022689A 1989-09-26 1989-09-26 Optically active hemiacetal compound Granted JPH03112974A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25022689A JPH03112974A (en) 1989-09-26 1989-09-26 Optically active hemiacetal compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25022689A JPH03112974A (en) 1989-09-26 1989-09-26 Optically active hemiacetal compound

Publications (2)

Publication Number Publication Date
JPH03112974A true JPH03112974A (en) 1991-05-14
JPH0559115B2 JPH0559115B2 (en) 1993-08-30

Family

ID=17204717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25022689A Granted JPH03112974A (en) 1989-09-26 1989-09-26 Optically active hemiacetal compound

Country Status (1)

Country Link
JP (1) JPH03112974A (en)

Also Published As

Publication number Publication date
JPH0559115B2 (en) 1993-08-30

Similar Documents

Publication Publication Date Title
US10011582B2 (en) Substituted delta-lactones and methods of preparing same
KR20140035484A (en) Method of producing beraprost
US5599954A (en) N-substituted-7-amino-5-hydroxy-3-oxoheptanoic acid derivatives and method for producing the same
JP2696933B2 (en) Substituted cyclic ketones and substituted cyclic enones and methods for their preparation
JPH03112974A (en) Optically active hemiacetal compound
WO2014094511A1 (en) Intermediates for synthesizing treprostinil and preparation method thereof as well as the preparation method of treprostinil thereby
JPH03112976A (en) Optically active delta-lactone compound
JPH03112980A (en) Production of optically active delta-lactone compound
JP2011523631A (en) Method for obtaining synatoline C3 and C1
JPH03112975A (en) Optically active delta-lactone compound
JPH066564B2 (en) Optically active carboxylic acid ester compound
JPH1017561A (en) Allylalcohol compounds and their production
JP2654835B2 (en) Optically active 4-en-6-ol compounds, intermediates for their production and methods for their production
JP2752489B2 (en) Novel macrocyclic compound and method for producing the same
JPH08231469A (en) Cyclopentanecarboxylic acid derivative and its production
JP2765575B2 (en) Process for producing substituted cyclopentenone and substituted cyclohexenone derivatives
JP2905024B2 (en) Method for producing optically active 6- (4-substituted inden-1-yl) -2-methyl-3-heptanols
JP3471067B2 (en) Method for producing optically active 6- (4-substituted inden-1-yl) -2-methyl-4-hepten-3-ols
JP2893473B2 (en) Process for producing (+)-equilenin and intermediate
JPH035473A (en) Optically active compound and its production
JPH04178345A (en) Optically active vinyl compound, its production intermediate and production thereof
JPH0651694B2 (en) Optically active compound
JPH04178374A (en) Optically active isooxazole derivative, production intermediate and production thereof
JPH0220616B2 (en)
JPH02104542A (en) Production of 2-hydroxy-3-methylenebicyclo(3.3.0)-octanes

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees